Christopher John Bond

USPTO Granted Patents = 18 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 117(Granted Patents)

Location History:

San Francisco, CA (US) (2010)
Fairport, NY (US) (2021)
San Mateo, CA (US) (2013 - 2022)
Mercer Island, WA (US) (2021 - 2024)

Company Filing History:

13 out of 94

Oncomed Pharmaceuticals, Inc.

The State University of New York

patents

4. 1 out of 310

Health Research, Inc.

patents

5. 1 out of 4

Mereo Biopharma 5, Inc.

patents

6. 1 out of 832,891

Other

patents

Years Active: 2010-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12053524 - Anti-podocalyxin antibodies and methods of using the same (2024-08-06),

2. 11512128 - VEGF/DLL4 binding agents and uses thereof (2022-11-29),

3. 11090383 - Anti-podocalyxin antibodies and methods of using the same (2021-08-17),

4. 10960088 - Macrocycles, cobalt and iron complexes of same, and methods of making and using same (2021-03-30),

5. 10730940 - VEGF/DLL4 binding agents and uses thereof (2020-08-04),

6. 9879084 - Modified immunoglobulin molecules that specifically bind human VEGF and DLL4 (2018-01-30),

7. 9873726 - Methods for identifying and isolating cells expressing a polypeptide (2018-01-23),

8. 9598497 - RSPO3 binding agents and uses thereof (2017-03-21),

9. 9574009 - Polynucleotides encoding VEGF/DLL4 binding agents (2017-02-21),

10. 9422546 - Methods for identifying and isolating cells expressing a polypeptide (2016-08-23),

11. 9376488 - VEGF binding antibodies (2016-06-28),

12. 9181333 - RSPO3 binding agents and uses thereof (2015-11-10),

13. 9168300 - MET-binding agents and uses thereof (2015-10-27),

14. 9023621 - Methods for identifying and isolating cells expressing a polypeptide (2015-05-05),

15. 8945878 - Methods for identifying and isolating cells expressing a polypeptide (2015-02-03),

Title: The Innovative Journey of Christopher John Bond

Introduction: Christopher John Bond, a talented inventor based in San Mateo, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Christopher John Bond's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a cutting-edge wearable technology for monitoring health metrics in real-time.

Career Highlights: With a career spanning over two decades, Christopher John Bond has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on improving daily lives.

Collaborations: Throughout his career, Christopher John Bond has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking products.

Conclusion: Christopher John Bond's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.